Godefridus J. Peters

Université de Bordeaux — France

Medicine · Health Sciences

103h-index52.5kcitations1.4kworks1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(284), Biochemical and Molecular Research(181), Pancreatic and Hepatic Oncology Research(174), Lung Cancer Treatments and Mutations(133), Cancer therapeutics and mechanisms(119)

Publications1.4k total

Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer
Cancer Drug Resistance·2025Open Access
Publisher Correction: Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025Open Access
Unravelling gemcitabine resistance in pancreatic cancer: omics and pharmacological insights to unveil key molecular determinants
Pancreatology·2025
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
Exploration of Targeted Anti-tumor Therapy·2025Open Access
Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025
Novel Pyrazolo [1,5‐a]−1,3,5‐Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models
ChemMedChem·2025Open Access
HSP90 inhibition reverses resistance to TRAIL-induced apoptosis in non-small cell lung cancer cells
Academia oncology.·2025· 1 citedOpen Access
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy
Journal of Experimental & Clinical Cancer Research·2025Open Access
Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels
Journal of Cancer Metastasis and Treatment·2025· 1 citedOpen Access
128P Cytotoxicity of arfolitixorin versus leucovorin (LEU) with 5-fluorouracil (5FU) and oxaliplatin in colorectal cancer (CRC) patient-derived tumoroids (PDTs)
Annals of Oncology·2025Open Access
Novel Pyrazolo [1,5-A]-1,3,5-Triazine Derivatives as Cdk7 Inhibitors: Synthesis and Biological Insights in Pdac Models
SSRN Electronic Journal·2025Open Access
Increased potentiation of 5-fluorouracil induced thymidylate synthase inhibition by 5,10-methylenetetrahydrofolate (arfolitixorin) compared to leucovorin in patients with colorectal liver metastases; The Modelle-001 Trial
BJC Reports·2024· 7 citedOpen Access
The diagnostic and prognostic value of <i>C1orf174 </i>in colorectal cancer
Bioimpacts·2024· 2 citedOpen Access
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Expert Opinion on Investigational Drugs·2024· 5 citedOpen Access
The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity
Frontiers in Pharmacology·2024· 2 citedOpen Access
Management of neurological symptoms in Lesch-Nyhan disease: A systematic review
Neuroscience & Biobehavioral Reviews·2024· 5 citedOpen Access
Obituary to Lynette Fairbanks, PhD
Nucleosides Nucleotides & Nucleic Acids·2024Open Access
Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture
Nucleosides Nucleotides & Nucleic Acids·2024· 1 cited
Effects of lactate dehydrogenase A and GLUT1 inhibition on human endothelial cell migration in relation to their intracellular nucleotide pool
Nucleosides Nucleotides & Nucleic Acids·2024· 1 cited
Evaluation of the combination of gemcitabine, carboplatin, and lactate dehydrogenase A inhibitor on malignant mesothelioma
Nucleosides Nucleotides & Nucleic Acids·2024· 1 citedOpen Access
page 1 of 68Next →

Frequent Co-authors

Herbert M. Pinedo(11), Clive Dickson(10), Elisa Giovannetti(10), Gerrit Jansen(7), Andries M. Bergman(6), C.L. van der Wilt(5), Kees Smid(5), Daron Smith(4), Niccola Funel(4), Paul Noordhuis(4), David Parry(4), Stewart Bates(4), Rik J. Scheper(3), Leticia G. León(3), Romano Danesi(3), Yehuda G. Assaraf(3), Gertjan J.L. Kaspers(3), Sybren L. Meijer(3), C.J. van Groeningen(3), Sharon Brookes(3)